Ocugen Inc
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase… Read more
Ocugen Inc (OCGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -3.656x
Based on the latest financial reports, Ocugen Inc (OCGN) has a cash flow conversion efficiency ratio of -3.656x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.92 Million) by net assets ($3.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ocugen Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Ocugen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ocugen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ocugen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
COOR Service Management AB
ST:COOR
|
0.071x |
|
Esso Thailand PCL
STU:JAV
|
0.222x |
|
Rami Levi Chain Stores Hashikma Marketing 2006 Ltd
PINK:RLEVF
|
0.250x |
|
Aegean Airlines S.A
PINK:AGZNF
|
0.327x |
|
Shanghai Xinpeng Industry Co Ltd
SHE:002328
|
0.059x |
|
NGERN TID LOR-NVDR- BA37
F:70V0
|
N/A |
|
Gs Retail
KO:007070
|
0.104x |
|
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Ocugen Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Ocugen Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $29.63 Million | $-42.14 Million | -1.422x | +7.03% |
| 2023-12-31 | $40.56 Million | $-62.05 Million | -1.530x | -88.38% |
| 2022-12-31 | $73.98 Million | $-60.08 Million | -0.812x | -62.31% |
| 2021-12-31 | $95.82 Million | $-47.94 Million | -0.500x | +26.70% |
| 2020-12-31 | $21.55 Million | $-14.71 Million | -0.683x | +55.48% |
| 2019-12-31 | $11.02 Million | $-16.89 Million | -1.533x | -104.45% |
| 2018-12-31 | $-458.00K | $-15.78 Million | 34.448x | +1586.17% |
| 2017-12-31 | $-11.27 Million | $-23.02 Million | 2.043x | +207.70% |
| 2016-12-31 | $13.57 Million | $-25.74 Million | -1.897x | -78.10% |
| 2015-12-31 | $28.20 Million | $-30.03 Million | -1.065x | -213.69% |
| 2014-12-31 | $54.21 Million | $-18.41 Million | -0.340x | -267.87% |
| 2013-12-31 | $-75.55 Million | $-15.28 Million | 0.202x | -67.41% |
| 2012-12-31 | $-19.71 Million | $-12.23 Million | 0.621x | -- |